FAB classifications, phosphorylation patterns, and IL-6 secretion levels of patients with AML
| Patient . | FAB . | Constitutive Tyr705 and Ser727 phosphorylation . | IL-6 secretion (pg/mL) . |
|---|---|---|---|
| 1 | M2 | + | 5924 |
| 2 | M4 | − | 0 |
| 3 | M0 | − | 323 |
| 4 | M4 | − | 0 |
| 5 | M4 | − | 0 |
| 6 | M2 | − | 0 |
| 7 | M1 | − | 0 |
| 8 | M4 | − | 0 |
| 9 | M5A | − | 0 |
| 10 | M2 | − | 0 |
| 11 | M5A | + | 23667 |
| 12 | M1 | − | 0 |
| 13 | M1 | − | 0 |
| 14 | M5 | + | 4058 |
| 15 | M4 | − | 0 |
| 16 | M2 | − | 0 |
| 17 | M2 | − | 0 |
| 18 | M0 | + | 7040 |
| 19 | M2 | + | 946 |
| 20 | M2 | − | 208 |
| Patient . | FAB . | Constitutive Tyr705 and Ser727 phosphorylation . | IL-6 secretion (pg/mL) . |
|---|---|---|---|
| 1 | M2 | + | 5924 |
| 2 | M4 | − | 0 |
| 3 | M0 | − | 323 |
| 4 | M4 | − | 0 |
| 5 | M4 | − | 0 |
| 6 | M2 | − | 0 |
| 7 | M1 | − | 0 |
| 8 | M4 | − | 0 |
| 9 | M5A | − | 0 |
| 10 | M2 | − | 0 |
| 11 | M5A | + | 23667 |
| 12 | M1 | − | 0 |
| 13 | M1 | − | 0 |
| 14 | M5 | + | 4058 |
| 15 | M4 | − | 0 |
| 16 | M2 | − | 0 |
| 17 | M2 | − | 0 |
| 18 | M0 | + | 7040 |
| 19 | M2 | + | 946 |
| 20 | M2 | − | 208 |